Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223

被引：0
|
作者：
dos Reis, Rodolfo Borges [1 ]
Muglia, Valdair [2 ]
Faria, Eliney F. [3 ,4 ]
机构：
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cirurgia & Anat, Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Imagens Med Radioterapia & Oncohematol, Ribeirao Preto, SP, Brazil
[3] Hosp Felicio Rocho, Belo Horizonte, MG, Brazil
[4] Hosp Amor Barretos, Dept Urol, Barretos, SP, Brazil
来源：
INTERNATIONAL BRAZ J UROL | 2020年 / 46卷 / 04期
关键词：
D O I：
10.1590/S1677-5538.0343.1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：612 / 613
页数：2
相关论文
共 50 条
  • [31] The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
    Sartor, Oliver
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 570 - 572
  • [32] The current evidence on prognostic factors in metastatic castration-resistant prostate cancer patients treated with Radium-223
    Maggi, Martina
    Gandaglia, Giorgio
    Rajwa, Pawel
    Martini, Alberto
    Marra, Giancarlo
    EAU YAU prostate Canc Working party
    MINERVA UROLOGY AND NEPHROLOGY, 2022, 74 (06): : 791 - 793
  • [33] Prediction of hematological toxicity in Radium-223 therapy in patients with advanced metastatic castration-resistant prostate cancer
    Fosbol, M. O.
    Petersen, P. M.
    Kjaer, A.
    Mortensen, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S330 - S330
  • [34] Predictors for survival after radium-223 (R223) treatment for castration-resistant metastatic prostate cancer.
    Anderson, Eric
    Wong, William
    Mohammadi, Homan
    Daniels, Thomas Backus
    Tzou, Katherine S.
    Schild, Steven E.
    Keole, Sameer R.
    Choo, Richard
    Bryce, Alan H.
    Thai Huu Ho
    Quevedo, Fernando
    Vora, Sujay A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistant prostate cancer
    Vidal, M.
    Cardenas-Perilla, R.
    Delgado, A.
    Moron, S.
    Blair, J. L. Londono
    Vega, I.
    Ochoa, J. J. Correa
    Rojas, J.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 310 - 317
  • [36] Circulating Tumor Cells and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Pleskow, H.
    Otani, K.
    Kusaka, E.
    Ukleja, J.
    Balza, R.
    Fisher, R.
    Broderick, K.
    Maheswaran, S.
    Haber, D.
    Saylor, P. J.
    Miyamoto, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E534 - E535
  • [37] Radium-223 Dichloride for Metastatic Castration-resistant Prostate Cancer: The Urologist's Perspective
    Shore, Neal D.
    UROLOGY, 2015, 85 (04) : 717 - 724
  • [38] EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
    Thorsten D. Poeppel
    Daria Handkiewicz-Junak
    Michael Andreeff
    Alexander Becherer
    Andreas Bockisch
    Eva Fricke
    Lilli Geworski
    Alexander Heinzel
    Bernd J. Krause
    Thomas Krause
    Markus Mitterhauser
    Wilfried Sonnenschein
    Lisa Bodei
    Roberto C. Delgado-Bolton
    Michael Gabriel
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 824 - 845
  • [39] Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Saylor, Philip J.
    Otani, Keisuke
    Balza, Rene
    Ukleja, Jacob
    Pleskow, Haley
    Fisher, Rebecca
    Kusaka, Erika
    Otani, Yukako S.
    Badusi, Priscilla Oluwakemi
    Smith, Matthew R.
    Meneely, Erika
    Olivier, Kara
    Lowe, Alarice C.
    Toner, Mehmet
    Maheswaran, Shyamala
    Haber, Daniel A.
    Yeap, Beow Y.
    Lee, Richard J.
    Miyamoto, David T.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [40] Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223
    Rodriguez-Vida, A.
    Torregrosa, M. D.
    Pinto, A.
    Climent, M. A.
    Olmos, D.
    Carles, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 679 - 686
12345